IP Pages 2019: The inevitable loss of billions in patent rights

22-01-2019

Paul J Sutton

IP Pages 2019: The inevitable loss of billions in patent rights

andreypopov / iStockphoto.com

A hypothetical scenario is set forth below to illustrate what occurs among dozens of companies holding patents covering highly successful pharmaceuticals. While the scenario relates to pharmaceuticals, the same circumstances will occur for mechanical, chemical, electrical, software, and business method devices and systems.


US, Sutton Magidoff, patent rights, USPTO, pharmaceuticals, patent monopoly, big pharma, innovative products, Hatch-Waxman Act

WIPR